- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 22.99M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $460.38M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $369.84M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $77.86M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $46.56M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $147.04M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $115.56M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $606.92M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $503.37M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.35B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.25B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 23.02M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $10.34M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $26.91M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $147.24M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.12B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.04B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $4.97 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $4.97 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $9.23M |
| Net Income | Q1 2025 · Mar 31, 2024 | $114.42M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $136.04M |
| Revenue | Q1 2025 · Mar 31, 2024 | $174.14M |